N-[(1,1-二甲基乙氧基)羰基]-4-碘-苯丙氨酸 | 103882-09-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-[(1,1-二甲基乙氧基)羰基]-4-碘-苯丙氨酸
• 英文名称: N-Boc-DL-4-iodophenylalanine
• 英文别名: Boc-4-iodophenylalanine；N-tert.-Butoxycarbonyl-4-iodphenylalanin；2-tert-butoxycarbonylamino-3-(4-iodophenyl)-propanoic acid；2-tert-butoxycarbonylamino-3-(4-iodophenyl)-propionic acid；Boc-p-iodo-DL-Phe-OH；3-(4-iodophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
• CAS: 103882-09-3
• 化学式: C₁₄H₁₈INO₄
• 分子量: 391.206
• InChiKey: JZLZDBGQWRBTHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[(1,1-二甲基乙氧基)羰基]-4-碘-苯丙氨酸 在 四(三苯基膦)钯 potassium carbonate 作用下， 以 DMF (N,N-dimethyl-formamide) 、 乙醇 、 水 、 甲苯 为溶剂， 反应 18.0h， 生成 2-tert-butoxycarbonylamino-3-(4'-dibenzofuran-4-yl-biphenyl-4-yl)-propanoic acid methyl ester
  参考文献：
  名称：

  [EN] SUBSTITUTED AMINO CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B
  [FR] ACIDES AMINO-CARBOXYLIQUES SUBSTITUES

  摘要：

  公开号：

  WO2004099171A3

文献信息

• IAP ANTAGONISTS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160376307A1

  公开（公告）日：2016-12-29

  There are disclosed compounds that modulate the activity of inhibitors of apoptosis (IAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

  披露了调节凋亡抑制因子（IAPs）活性的化合物，包含该化合物的药物组合物以及利用本发明的化合物治疗增生性疾病和凋亡失调疾病，如癌症的方法。
• Photocatalytic decarboxylative alkenylation of α-amino and α-hydroxy acid-derived redox active esters by NaI/PPh₃ catalysis
  作者：Ya-Ting Wang、Ming-Chen Fu、Bin Zhao、Rui Shang、Yao Fu

  DOI：10.1039/c9cc09654j

  日期：——

  Herein, we report the photocatalytic decarboxylative alkenylation reactions of N-(acyloxy)phthalimide derived from α-amino and α-hydroxy acids with 1,1-diarylethene, and with cinnamic acid derivatives through double decarboxylation, using sodium iodide and triphenylphosphine as redox catalysts. The reaction proceeds under mild irradiation conditions with visible blue light (440 nm or 456 nm) in an

  在本文中，我们报道了使用碘化钠和三苯基膦作为氧化还原催化剂，由α-氨基和α-羟基酸衍生的N-（酰氧基）邻苯二甲酰亚胺与1,1-二芳基乙烯和肉桂酸衍生物通过双重脱羧的光催化脱羧烯基化反应。。该反应在丙酮溶剂中在温和的辐照条件下用可见的蓝光（440 nm或456 nm）进行，而无需使用基于过渡金属或有机染料的光氧化还原催化剂。反应通过N-（酰氧基）邻苯二甲酰亚胺和NaI / PPh 3的瞬时自组装生色团的光活化而进行。溶剂化在反应性中起关键作用。
• Photoinduced Copper(I)-Catalyzed Cyanation of Aromatic Halides at Room Temperature
  作者：Kicheol Kim、Soon Hyeok Hong

  DOI：10.1002/adsc.201700213

  日期：2017.7.17

  copper(I)-catalyzed cyanation of aromatic halides at room temperature has been developed. The sp2 cyanation reaction exhibits outstanding tolerance to functional groups including primary amines and carboxylic acids, and chemoselectivity to SN2-reactive alkyl chlorides. Mechanistic investigations indicate that the reaction occurs via a single-electron transfer (SET) between the aryl halide and an excited copper(I)

  已经开发出在室温下第一光诱导的铜（I）催化的芳族卤化物的氰化。的SP 2氰化反应呈现突出的耐受性官能团，包括伯胺和羧酸，和化学选择性至S Ñ 2反应性烷基氯化物。机理研究表明，该反应是通过芳基卤化物与激发的氰化铜（I）催化中间体之间的单电子转移（SET）发生的。
• Visible-Light-Induced C–H Bond Aminoalkylation of Heterocycles by the Decarboxylation Coupling of Amino Acids
  作者：Yifan Li、Changhui Dai、Shentong Xie、Ping Liu、Peipei Sun

  DOI：10.1021/acs.orglett.1c02014

  日期：2021.8.6

  An efficient visible-light-induced decarboxylative coupling reaction of N-protecting α-amino acids with heterocycles for the generation of aminoalkylated heterocycles is presented. A series of aminoalkylated heterocycles were obtained in moderate to good yields. Attractive features of this process include the generation of aminomethyl radical by an inexpensive organic photocatalyst under transition-metal-free

  提出了一种有效的可见光诱导的N-保护 α-氨基酸与杂环的脱羧偶联反应，用于生成氨基烷基化杂环。以中等至良好的产率获得了一系列氨基烷基化杂环。该过程的吸引人的特点包括在无过渡金属条件下通过廉价的有机光催化剂产生氨甲基自由基。
• SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES
  申请人：Caroff Eva

  公开号：US20110046089A1

  公开（公告）日：2011-02-24

  The present invention relates to compounds of formula I wherein R 1 , R 2 , R 4 , R 5 , R a , R b , n, W and Z are as defined in the application, their preparation and their use as P2Y 12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

  本发明涉及式I化合物的制备及其用途，式中R1、R2、R4、R5、Ra、Rb、n、W和Z的定义如申请中所述，以及它们作为P2Y12受体拮抗剂用于治疗和/或预防外周血管、内脏血管、肝脏血管和肾脏血管、心血管和脑血管疾病或与血小板聚集相关状况的用途，包括人类和其他哺乳动物中的血栓症。